ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Cesca Therapeutics Inc

Cesca Therapeutics Inc (KOOL)

5.14
0.00
(0.00%)
終了 12月4日 6:00AM
5.14
0.00
( 0.00% )
プレマーケット: 9:00AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
5.14
買値
3.30
売値
5.22
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
時価総額
前日終値
5.14
始値
-
時刻
最終取引時間
-
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
3,137,000
配当利回り
-
PER
-0.90
1 株当たり利益 (EPS)
-5.73
歳入
9.45M
純利益
-17.98M

Cesca Therapeutics Inc について

Cesca Therapeutics Inc is clinical-stage biotechnology company. The company is engaged in developing and manufacturing automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. The company's device division, Therm... Cesca Therapeutics Inc is clinical-stage biotechnology company. The company is engaged in developing and manufacturing automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. The company's device division, ThermoGenesis Corp, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Cesca's clinical development division is leveraging its proprietary AutoXpress technology platform to develop autologous stem cell-based therapies that address significant unmet needs in the immuno-oncology, vascular, cardiology and orthopedic markets. 詳細を表示

セクター
Lab Apparatus And Furniture
業界
Lab Apparatus And Furniture
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-

KOOL 最新ニュース

Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus

Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus ThermoGenesis to Focus on Developing Automated Cell Processing Tools and Services for the Cell and Gene Therapy...

Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference

Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference PR Newswire RANCHO CORDOVA, Calif., Oct. 24, 2019 RANCHO CORDOVA, Calif., Oct. 24, 2019...

Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Serv...

Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Services ImmuneCyte to Begin Operations in Fourth Quarter of 2019 PR...

Cesca Therapeutics To Present At The 2019 Bio Investor Forum

Cesca Therapeutics To Present At The 2019 Bio Investor Forum PR Newswire RANCHO CORDOVA, Calif., Oct. 14, 2019 RANCHO CORDOVA, Calif., Oct. 14, 2019 /PRNewswire/ -- Cesca Therapeutics Inc...

Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee

Cesca Therapeutics Announces Receipt Of $2 Million Upfront Distribution Fee PR Newswire RANCHO CORDOVA, Calif., Oct. 2, 2019 RANCHO CORDOVA, Calif., Oct. 2, 2019 /PRNewswire/ -- Cesca...

ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing Devices

ThermoGenesis Reports Performance Evaluations of X-Series® Cell Processing Devices PR Newswire RANCHO CORDOVA, Calif., Sept. 25, 2019 RANCHO CORDOVA, Calif., Sept. 25, 2019 /PRNewswire/ -- Cesca...

Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products

Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products PR Newswire RANCHO CORDOVA, Calif., Sept. 9, 2019 RANCHO CORDOVA, Calif...

Cesca Therapeutics To Present At The H.C. Wainwright 21st Annual Global Investment Conference

Cesca Therapeutics To Present At The H.C. Wainwright 21st Annual Global Investment Conference PR Newswire RANCHO CORDOVA, Calif., Sept. 3, 2019 RANCHO CORDOVA, Calif., Sept. 3, 2019 /PRNewswire/...

Cesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate Update

Cesca Therapeutics Announces Improved Second Quarter 2019 Financial Results and Provides Corporate Update Revenue Grows by 115% and the Company Records Positive Adjusted EBITDA for the Second...

Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On Aug...

Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On August 13 PR Newswire RANCHO CORDOVA, Calif., Aug. 6, 2019 RANCHO...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
CNEYCN Energy Group Inc
US$ 0.807
(155.70%)
36.59M
HRTXHeron Therapeautics Inc
US$ 2.175
(84.32%)
11.18M
HTOOFusion Fuel Green PLC
US$ 0.571
(79.56%)
6.07M
SVMHSRIVARU Holding Ltd
US$ 0.034
(54.55%)
178.65M
XCURExicure Inc
US$ 17.60
(25.71%)
110.35k
ORISOriental Rise Holdings Ltd
US$ 7.37
(-38.33%)
26.02k
CTNTCheetah Net Supply Chain Service Inc
US$ 3.94
(-19.43%)
159.85k
LRFCLogan Ridge Finance Corporation
US$ 20.01
(-19.35%)
5
MOFGMidWestOne Financial Group
US$ 26.50
(-19.21%)
168
ZJKZJK Industrial Company Ltd
US$ 14.15
(-18.02%)
164.31k
SVMHSRIVARU Holding Ltd
US$ 0.034
(54.55%)
178.65M
AGRIAgriFORCE Growing Systems Ltd
US$ 0.0335
(15.92%)
50.92M
TANHTantech Holdings Ltd
US$ 0.1909
(16.40%)
38.44M
CNEYCN Energy Group Inc
US$ 0.807
(155.70%)
36.59M
VIRXViracta Therapeutics Inc
US$ 0.2028
(24.57%)
30.32M

KOOL Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock